Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2024 Feb 3;16(2):e53518.
doi: 10.7759/cureus.53518. eCollection 2024 Feb.

Complex Management of Basal Cell Carcinoma in a Frail Patient

Affiliations
Case Reports

Complex Management of Basal Cell Carcinoma in a Frail Patient

Kawaiola Cael Aoki et al. Cureus. .

Abstract

Basal cell carcinoma (BCC) is one of the most common cancers diagnosed in older patients and has low mortality. Surgical versus medical management is considered in patients with multiple comorbidities and limited life expectancy (LLE), where the risk-to-benefit ratio must be carefully assessed. Watchful waiting (WW) is a viable option for some patients with severe LLE when follow-up care can be provided vigilantly and frequently. Special consideration should be given to morbidity factors such as tumor growth, bleeding, pain, and social withdrawal that negatively affect the quality of life. We present the case of a 75-year-old male with a past medical history of multiple system atrophy, who presented with a BCC on the ear and face. We discuss the management of this patient and factors that may have led to the inappropriate use of WW.

Keywords: basal cell carcinoma (bcc); dermato-oncology; dermato-surgery; mohs surgery; watchful waiting.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

Figure 1
Figure 1. Initial presentation of basal cell carcinoma of the right ear
Figure 2
Figure 2. Healing defect at two weeks post-Mohs
Figure 3
Figure 3. Recurrence of basal cell carcinoma at six-month follow-up

Similar articles

References

    1. Skin cancer epidemics in the elderly as an emerging issue in geriatric oncology. Garcovich S, Colloca G, Sollena P, et al. Aging Dis. 2017;8:643–661. - PMC - PubMed
    1. Non-melanoma skin cancer. Madan V, Lear JT, Szeimies RM. Lancet. 2010;375:673–685. - PubMed
    1. Metastatic basal cell carcinoma: prognosis dependent on anatomic site and spread of disease. McCusker M, Basset-Seguin N, Dummer R, et al. Eur J Cancer. 2014;50:774–783. - PubMed
    1. Treatment of nonfatal conditions at the end of life: nonmelanoma skin cancer. Linos E, Parvataneni R, Stuart SE, Boscardin WJ, Landefeld CS, Chren MM. JAMA Intern Med. 2013;173:1006–1012. - PMC - PubMed
    1. Mohs micrographic surgery and surgical excision for nonmelanoma skin cancer treatment in the Medicare population. Viola KV, Jhaveri MB, Soulos PR, Turner RB, Tolpinrud WL, Doshi D, Gross CP. Arch Dermatol. 2012;148:473–477. - PubMed

Publication types

LinkOut - more resources